Exelixis, Inc. (EXEL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Exelixis, Inc. (EXEL)

EXEL 41.42

+1.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (288)	10/14/2006 8:48:26 PM
From: dr.praveen	Read Replies (1) of 930

Some ramblings...On one hand it makes me excited to see all the new compounds,OTOH I wonder about the quality of them and how many will fizzle. I wish the first in line was XL880 which inhibits the novel target Met and VEGFR2 :-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next